Long COVID and ME/CFS trials in Saudi Arabia
1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of Apabetalone in Subjects With Long -COVID
- Where
- Al Mubarraz
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Resverlogix Corp
See details and how to joinNCT06590324